{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:31:22Z","timestamp":1792067482138,"version":"4.4.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81470526"],"award-info":[{"award-number":["81470526"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670369"],"award-info":[{"award-number":["81670369"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870214"],"award-info":[{"award-number":["81870214"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ejphar.2024.176351","type":"journal-article","created":{"date-parts":[[2024,1,28]],"date-time":"2024-01-28T01:43:21Z","timestamp":1706406201000},"page":"176351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["NADPH oxidase 2 inhibitor GSK2795039 prevents doxorubicin-induced cardiac atrophy by attenuating cardiac sympathetic nerve terminal abnormalities and myocyte autophagy"],"prefix":"10.1016","volume":"967","author":[{"given":"Hui-Ping","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Xia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Fang","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nian-Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Pu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Zhong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Guo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2024.176351_bib1","doi-asserted-by":"crossref","first-page":"H795","DOI":"10.1152\/ajpheart.00253.2017","article-title":"Vitamin C mitigates oxidative\/nitrosative stress and inflammation in doxorubicin-induced cardiomyopathy","volume":"313","author":"Akolkar","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2024.176351_bib2","article-title":"Novel mechanisms of anthracycline-induced cardiovascular toxicity: a focus on thrombosis, cardiac atrophy, and programmed cell death","volume":"8","author":"Antoniak","year":"2021","journal-title":"Front Cardiovasc.Med."},{"key":"10.1016\/j.ejphar.2024.176351_bib3","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1177\/0960327112467043","article-title":"N-acetylcysteine prevents doxorubucine-induced cardiotoxicity in rats","volume":"32","author":"Arica","year":"2013","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.ejphar.2024.176351_bib4","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1161\/CIRCRESAHA.111.252742","article-title":"AMP-activated protein kinase regulates E3 ligases in rodent heart","volume":"109","author":"Baskin","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2024.176351_bib5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/1440-1681.13583","article-title":"Enhanced oxidative stress mediates pathological autophagy and necroptosis in cardiac myocytes in pressure overload induced heart failure in rats","volume":"49","author":"Chi","year":"2022","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejphar.2024.176351_bib6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41419-021-03614-x","article-title":"Regulated cell death pathways in doxorubicin-induced cardiotoxicity","volume":"12","author":"Christidi","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2024.176351_bib7","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1172\/JCI110328","article-title":"Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine","volume":"68","author":"Doroshow","year":"1981","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2024.176351_bib8","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4161\/oxim.3.3.12106","article-title":"Oxidative stress and autophagy in cardiac disease, neurological disorders, aging and cancer","volume":"3","author":"Essick","year":"2010","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2024.176351_bib9","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jcmg.2018.05.012","article-title":"Anthracycline therapy is associated with cardiomyocyte atrophy and preclinical manifestations of heart disease","volume":"11","author":"Ferreira de","year":"2018","journal-title":"JACC.Cardiovasc.Imaging"},{"key":"10.1016\/j.ejphar.2024.176351_bib10","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1161\/01.CIR.0000160359.49478.C2","article-title":"Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity","volume":"111","author":"Fisher","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2024.176351_bib11","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1161\/CIRCRESAHA.115.307604","article-title":"Chemical endoplasmic reticulum chaperone alleviates doxorubicin-induced cardiac dysfunction","volume":"118","author":"Fu","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2024.176351_bib12","first-page":"1513","article-title":"The cardioprotective role of N-acetyl cysteine amide in the prevention of doxorubicin and trastuzumab-mediated cardiac dysfunction","volume":"32","author":"Goyal","year":"2016","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.ejphar.2024.176351_bib13","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1089\/ars.2014.6202","article-title":"Discovery of GSK2795039, a novel small molecule NADPH oxidase 2 inhibitor","volume":"23","author":"Hirano","year":"2015","journal-title":"Antioxid.Redox.Signal."},{"key":"10.1016\/j.ejphar.2024.176351_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2021.12.006","article-title":"The role of autophagy in death of cardiomyocytes","volume":"165","author":"Ikeda","year":"2022","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2024.176351_bib15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3390\/nu10010044","article-title":"Possible mechanisms of the prevention of doxorubicin toxicity by cichoric acid-antioxidant nutrient","volume":"10","author":"Jablonska-Trypuc","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.ejphar.2024.176351_bib16","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s002590050563","article-title":"Evaluation of cardiac adrenergic neuronal damage in rats with doxorubicin-induced cardiomyopathy using iodine-131 MIBG autoradiography and PGP 9.5 immunohistochemistry","volume":"27","author":"Jeon","year":"2000","journal-title":"Eur. J. Nucl. Med."},{"key":"10.1016\/j.ejphar.2024.176351_bib17","first-page":"219","article-title":"[Protein interacting with kinase Calpha mediates the down-regulation of myocardial norepinephrine transporter expression in mice with adriamycin-induced congestive heart failure]","volume":"42","author":"Jin","year":"2014","journal-title":"Zhonghua Xinxueguanbing Zazhi"},{"key":"10.1016\/j.ejphar.2024.176351_bib18","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004560","article-title":"Left ventricular mass change after anthracycline chemotherapy","volume":"11","author":"Jordan","year":"2018","journal-title":"Circ.Heart Fail."},{"issue":"Suppl. 2","key":"10.1016\/j.ejphar.2024.176351_bib19","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1097\/00005344-200000006-00008","article-title":"Chronic adriamycin treatment impairs myocardial interstitial neuronal release of norepinephrine and epinephrine","volume":"36","author":"Kawada","year":"2000","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176351_bib20","doi-asserted-by":"crossref","first-page":"E80","DOI":"10.1161\/01.RES.86.7.e80","article-title":"Reduced myocardial nerve growth factor expression in human and experimental heart failure","volume":"86","author":"Kaye","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2024.176351_bib21","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1161\/CIRCRESAHA.111.257253","article-title":"Development, maturation, and transdifferentiation of cardiac sympathetic nerves","volume":"110","author":"Kimura","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2024.176351_bib22","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1074\/jbc.M109.070037","article-title":"Transcription factor GATA4 inhibits doxorubicin-induced autophagy and cardiomyocyte death","volume":"285","author":"Kobayashi","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2024.176351_bib23","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1113\/JP270917","article-title":"Innervating sympathetic neurons regulate heart size and the timing of cardiomyocyte cell cycle withdrawal","volume":"593","author":"Kreipke","year":"2015","journal-title":"J.Physiol"},{"key":"10.1016\/j.ejphar.2024.176351_bib24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI73943","article-title":"Autophagy in cardiovascular biology","volume":"125","author":"Lavandero","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2024.176351_bib25","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1113\/EP085586","article-title":"Distinct changes of myocyte autophagy during myocardial hypertrophy and heart failure: association with oxidative stress","volume":"101","author":"Li","year":"2016","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.ejphar.2024.176351_bib26","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.bbadis.2015.01.010","article-title":"Activation of NADPH oxidase mediates increased endoplasmic reticulum stress and left ventricular remodeling after myocardial infarction in rabbits","volume":"1852","author":"Li","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2024.176351_bib27","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1161\/CIRCULATIONAHA.115.017443","article-title":"Doxorubicin blocks cardiomyocyte autophagic flux by inhibiting lysosome acidification","volume":"133","author":"Li","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2024.176351_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2019.06.007","article-title":"Autophagy and cancer therapy cardiotoxicity: from molecular mechanisms to therapeutic opportunities","volume":"1867","author":"Li","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.ejphar.2024.176351_bib29","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1745-7254.2007.00585.x","article-title":"Cardiac sympathetic nerve terminal function in congestive heart failure","volume":"28","author":"Liang","year":"2007","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2024.176351_bib30","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1111\/bph.13773","article-title":"Signalling mechanisms underlying doxorubicin and Nox2 NADPH oxidase-induced cardiomyopathy: involvement of mitofusin-2","volume":"174","author":"McLaughlin","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176351_bib31","doi-asserted-by":"crossref","first-page":"8105","DOI":"10.3390\/ijms21218105","article-title":"Protection against doxorubicin-induced cardiac dysfunction is not maintained following prolonged autophagy inhibition","volume":"21","author":"Montalvo","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.176351_bib32","doi-asserted-by":"crossref","first-page":"R227","DOI":"10.1152\/ajpregu.00299.2019","article-title":"Doxorubicin-induced oxidative stress differentially regulates proteolytic signaling in cardiac and skeletal muscle","volume":"318","author":"Montalvo","year":"2020","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ejphar.2024.176351_bib33","article-title":"Neurotoxic effect of doxorubicin treatment on cardiac sympathetic neurons","volume":"23, 11098","author":"Moro","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.176351_bib34","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.cardfail.2016.04.009","article-title":"Heart failure therapies for end-stage chemotherapy-induced cardiomyopathy","volume":"22","author":"Mukku","year":"2016","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ejphar.2024.176351_bib35","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nm1574","article-title":"The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress","volume":"13","author":"Nakai","year":"2007","journal-title":"Nat.Med."},{"key":"10.1016\/j.ejphar.2024.176351_bib36","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/CIRCRESAHA.116.303791","article-title":"Therapeutic targeting of autophagy: potential and concerns in treating cardiovascular disease","volume":"116","author":"Orogo","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2024.176351_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-12060-9","article-title":"Neferine ameliorates cardiomyoblast apoptosis induced by doxorubicin: possible role in modulating NADPH oxidase\/ROS-mediated NFkappaB redox signaling cascade","volume":"7","author":"Priya","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2024.176351_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-physiol-021317-121427","article-title":"The role of autophagy in the heart","volume":"80","author":"Sciarretta","year":"2018","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ejphar.2024.176351_bib39","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1161\/CIRCRESAHA.116.307474","article-title":"Aging and autophagy in the heart","volume":"118","author":"Shirakabe","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2024.176351_bib40","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0735-1097(01)01596-0","article-title":"Antioxidant vitamins attenuate oxidative stress and cardiac dysfunction in tachycardia-induced cardiomyopathy","volume":"38","author":"Shite","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2024.176351_bib41","doi-asserted-by":"crossref","first-page":"62","DOI":"10.15420\/cfr.2017:3:2","article-title":"Cardiac atrophy and heart failure in cancer","volume":"3","author":"Sweeney","year":"2017","journal-title":"Card. Fail. Rev."},{"key":"10.1016\/j.ejphar.2024.176351_bib42","first-page":"49","article-title":"Myocardial sympathetic dysinnervation in doxorubicin cardiomyopathy","volume":"27","author":"Takano","year":"1996","journal-title":"J. Cardiol."},{"key":"10.1016\/j.ejphar.2024.176351_bib43","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cardiores.2005.08.014","article-title":"Autophagy in cardiac myocyte homeostasis, aging, and pathology","volume":"68","author":"Terman","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2024.176351_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119214","article-title":"Schisandrin B prevents doxorubicin induced cardiac dysfunction by modulation of DNA damage, oxidative stress and inflammation through inhibition of MAPK\/p53 signaling","volume":"10","author":"Thandavarayan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2024.176351_bib45","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1113\/EP087552","article-title":"The NADPH oxidase inhibitor apocynin improves cardiac sympathetic nerve terminal innervation and function in heart failure","volume":"104","author":"Wang","year":"2019","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.ejphar.2024.176351_bib46","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005234","article-title":"Doxorubicin exposure causes subacute cardiac atrophy dependent on the striated muscle-specific ubiquitin ligase MuRF1","volume":"12","author":"Willis","year":"2019","journal-title":"Circ.Heart Fail."},{"key":"10.1016\/j.ejphar.2024.176351_bib47","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.yjmcc.2017.06.003","article-title":"LCZ696 improves cardiac function via alleviating Drp1-mediated mitochondrial dysfunction in mice with doxorubicin-induced dilated cardiomyopathy","volume":"108","author":"Xia","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2024.176351_bib48","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000439","article-title":"Macrophage migration inhibitory factor deficiency augments doxorubicin-induced cardiomyopathy","volume":"2","author":"Xu","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ejphar.2024.176351_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174260","article-title":"Sphingosine-1-phosphate induces myocyte autophagy after myocardial infarction through mTOR inhibition","volume":"907","author":"Yang","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176351_bib50","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/cvr\/cvs320","article-title":"Cardiac sympathetic neurons provide trophic signal to the heart via beta2-adrenoceptor-dependent regulation of proteolysis","volume":"97","author":"Zaglia","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2024.176351_bib51","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1113\/JP273120","article-title":"Cardiac sympathetic innervation, from a different point of (re)view","volume":"595","author":"Zaglia","year":"2017","journal-title":"J.Physiol"},{"key":"10.1016\/j.ejphar.2024.176351_bib52","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nm.4017","article-title":"CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis","volume":"22","author":"Zhang","year":"2016","journal-title":"Nat.Med."},{"key":"10.1016\/j.ejphar.2024.176351_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2023.116412","article-title":"GSK2795039 prevents RIP1-RIP3-MLKL-mediated cardiomyocyte necroptosis in doxorubicin-induced heart failure through inhibition of NADPH oxidase-derived oxidative stress","volume":"463","author":"Zhang","year":"2023","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176351_bib54","doi-asserted-by":"crossref","first-page":"9287","DOI":"10.1158\/0008-5472.CAN-10-2664","article-title":"Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with Doxorubicin chemotherapy","volume":"70","author":"Zhao","year":"2010","journal-title":"Cancer Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924000396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924000396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T23:27:01Z","timestamp":1757978821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924000396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":54,"alternative-id":["S0014299924000396"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176351","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NADPH oxidase 2 inhibitor GSK2795039 prevents doxorubicin-induced cardiac atrophy by attenuating cardiac sympathetic nerve terminal abnormalities and myocyte autophagy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176351","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"176351"}}